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1. Introduction 
The Fc region of IgG, comprising approximately 
the C-terminal half of the two heavy chains mediates 
most of the effector functions of the molecule (e.g. 
interaction with the complement system, cytophilic 
activity, placental transfer, etc.). A considerable 
body of evidence [ 1, 21 suggests that the heavy and 
light chains of IgG are folded into a series of ‘com- 
pact domains’ comprising some 110 residues and 
each containing a single intrachain disulphide bond. 
Each heavy chain is folded into four such domains; 
the two C-terminal domains of each chain (desig 
nated $2 and C,3) form the Fc region. Fragments 
corresponding to the C, 3 domain have been iso- 
lated and characterized 13, 41 and shown to be in- 
volved in the heterocytotropic activity of IgG [5]. 
Exposure of IgG to acid conditions has been shown 
to transiently render the region between C,2 and 
C,3 susceptible to proteolytic attack [6]. This 
approach has been used with Fc to prepare fragments 
related to C,2 which are capable of interacting 
with complement. 
2. Materials 
Human IgGlmyeloma proteins were isolated and 
Fc fragments prepared from them by plasmin diges- 
tion following previously published methods [7,8]. 
* This work was supported by grants (MT 4259 and MT 
1361) from the Medicai Research Council of Canada. 
Trypsin (Type XI-DCC treated) and soybean tryp 
sin inhibitor (Type 1-S) were obtained from Sigma 
Chemical Co. Antisera to Fc were prepared by ab- 
sorbing rabbit antiserum to T-chain with Fab frag- 
ment. Specific anti-CH2 serum was obtained by 
absorbing anti-Fc with pFc’ fragment (- CH3) pre- 
pared according to Turner and Bennich [3]. Dried 
guinea pig serum complement and sheep red cells 
were purchased from Connaught Medical Research 
Labs; rabbit hemolysin from Grand Island Biologi- 
cals and polystyrene latex particles (dia., 0.09 1 ym) 
from Dow Chemical Co. 
3. Methods and results 
Fc (20 mdml) in 0.15 M NaCl, 10 mM TrisHCl, 
pH 7.8 was titrated to pH 2.5 with 2 N HCl at 25”. 
After 5 min at this pH, sufficient trypsin solution 
(10 mg/ml in 1 .O mM HCI) was added to give an en- 
zyme to substrate ratio of 1 : 25 and the pH was 
rapidly readjusted to 7.8 with 2 M Tris. Serial sam- 
ples were removed between 10 set and 5 min and 
the trypsin inactivated with an equal weight of soy- 
bean inhibitor. Acid-urea starch gel electrophoresis 
showed that Fc had been cleaved. The optimum di- 
gestion time was near 45 set and this time was used 
in subsequent experiments. Samples of Fc incubated 
at pH 7.8 with trypsin for up to 3 hr, without prior 
exposure, showed no cleavage. Similarly, Fc adjust- 
ed to pH 2.5 for 5 min and returned to pH 7.8, in 
the absence of trypsin, showed no fragmentation. 
The digestion products of Fc were separated on a 
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Fig. 1. A) Chromatography of a tryptic digest of acid-treated Fc on a 90.0 X 5 .O cm column of Sephadex G-l 00 in 1 .O M acetic 
acid, 25 mM NaCl. The effluent was pooled into four fractions as indicated by the horizontal lines. B) Rechromatography of 
fraction 3 under similar conditions. The main peak was pooled, as indicated, and the protein used for detailed analysis. 
column of Sephadex G- 100 (90 X 5 cm) in 1 .O M 
acetic acid, 25 mM NaCl as shown in fig. 1. Four 
protein peaks were resolved and the fractions pooled 
as indicated in fig. 1 before dialysis against 100 mM 
acetic acid, pH 3.2. In earlier experiments residual 
tryptic activity was apparent at this stage. To pre- 
vent further digestion soybean trypsiri inhibitor 
coupled to Sepharose, according to the method of 
Cuatrecasas [9], was added prior to further dialysis 
against 0.15 M NaCI, 10 mM Tris, pH 7.8. The 
Sepharose was removed by centrifugation and the 
solutions concentrated by ultrafiltration. 
Preliminary characterisation of fractions 1 to 4 
was achieved on acid-urea starch gels (fig. 2a). 
Fraction 1 contained undigested Fc and two more 
rapidly migrating components which were also 
present in fraction 2. Other data (to be published) 
suggest hat these represent intermediate digestion 
products. Fractions 3 and 4 each contained essen- 
tialiy single components. Prior to further analysis 
fractions 3 and 4 were separately rec~omatographed 
on G-100 in 1.0 M acetic acid, 25 mM NaCl and the 
protein in the main peak dialysed against 0.15 M NaCl, 
10 mM Tris, pH 7.8 (fraction 3a shown in fig. 1). 
Fractions 3 and 4 gave reaction of antigenic non- 
identity on gel diffusion against anti-Fc and reac- 
tions of partial identity with Fc in the same system 
(fig. 2b). Fraction 4 gave a reaction of identity with 
pFc’ (E C&3). Fraction 3 showed a single precipitin 
line with anti-C,2 which fused with Fc; fraction 4 
gave no reaction. These observations indicated that 
3 and 4 were distinct components corresponding 
antigenically to C,2 and CH3, respectively. 
A partial amino acid analysis of fraction 3 after a 
20 hr acid hydrolysis is given in table 1. A striking 
similarity is apparent between the amino acid com- 
position of fraction 3 and that of residues 223 to 
334 (table 1) of the heavy chain sequence deter- 
mined for protein Eu [ 131. This latter sequence re- 
presents the N-terminal 111 residues of plasmin Fc 
and includes much of the ‘hinge’ region in addition 
to ($2. In contrast a comparison of the amino acid 
compositions of fraction 3 and pFc’ showed large 
differences (table 1). The N-terminal residue of 
fraction 3 was shown to be threonine, using the 
dansyi-Edman method; the same as the parent Fc- 
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Table 1 
Amino acid composition of fractions 3 and 4 isolated by column chromatography as shown in tig. I. 
Ohs?) 
Fraction 3 Fraction 4 Fraction 3 obs. 
minus fraction 4 
Ca1c.b) Diff. Ohs.‘) Cakd) Diff. iXlc.e) 
LYS 8.3 8 0 6.8 7 0 1 
His 3.7 4 0 3.3 3 0 1 
Arg 3.0 3 0 2.4 3 0 0 
Asp 10.4 10 0 11.0 11 0 1 
Thr 8.8 8 1 7.1 8 0 1 
Ser 7.1 6 1 11.9 15 3 8 
GlU 11.9 11 I 14.7 15 0 3 
Pro 12.6 13 0 11.2 10 1 3 
GLY 4.8 4 1 5.9 6 0 2 
Ala 3.4 3 0 2.8 3 0 0 
Val 13.4 15 2 8.7 9 0 4 
Met 1.1 I 0 0.9 2 f 1 
he 2.0 2 0 1.6 2 0 0 
Leu 8.0 8 0 8.1 4 4 4 
TYr 3.8 4 0 4.8 5 0 1 
Phe 3.0 3 0 3.9 4 0 1 
GluNHz 6.0 _ 0.0 _ _ _ 
Total differences (%) 6 (5.7%) 9 (8.4%) 31 (29%) 
a) Residues/8 residues of Ieucine. 
b, Calculated from composition of residues 223 to 334 of Eu sequence [ 131. 
‘) Residues/l 1 residues of aspartic acid. 
d, Calculated from composition of residues 335 to 446 of Eu sequence (131. 
e) These data have been included to stress the differences in composition between fraction 3 (putative CHZ) and CH3. 
fragment. The detection of ghrcosamine in fraction 
3 was particularly interesting since the only point 
of attachment of carbohydrate in human y-chain 
in asp-2?7 in the CB2 region [ 131. 
Preliminary physico-chemic~ studies on fraction 
3 yielded a sedimentation coefficient of 2.4 S in 
0.15 M NaCl, 10 mM Tris, pH 7.8 suggesting a molec- 
ular size near 22,000. Molecular weight determina- 
tions by sedimentation equilibrium after reduction 
and alkylation gave a value near 11,000. 
For complement fixation tests proteins were ag- 
gregated by adsorption onto polystyrene latex par- 
ticles [ lo]. Because of the differing affinities of IgG 
and the various fragments for polystyrene latex, 
different free protein concentrations were used in 
each test system in order to maintain a monolayer 
on the particles. The appropriate concentrations 
were determined for each protein by constructing 
adsorption isotherms as described by Oreskes and 
Singer [ 111. Quantitative complement fixation 
320 
tests were performed [ 121 and CHse units estimated 
from the intercepts of von Krogh plots using data 
from the 20-80% hemolysis range for each concen- 
tration of protein tested. Controls with either poly- 
styrene latex or protein alone showed no signi~cant 
complement consumption, results are shown in table 
2. The IgG, Fc and fraction 3 were all active in 
futing complement in a dose dependent fashion, 
whereas fraction 4 and Fab showed no ability to react 
with complement in this system. 
4. Discussion 
Exposure of Fc (or rabbit IgG [6] ) to acid pH ap- 
pears to render the region between C,2 and C,3 sus- 
ceptible to proteolysis. Conformational studies, using 
circular dichroism, showed that Fe undergoes a 
structural transition at acid pH which is fuIly revers- 
ible in less than 5 min after readjusting to pH 7.8 (to 
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Table 2 
Complement fixing by IgG and its fragments adsorbed onto 
polystyrene latex (P.L.) 
Protein Total 
P.L. bound 
protein (pg) 
Initial CHsn units 
CHso units consumed 
LgG 15.0 20.9 20.9 
1.5 20.9 12.7 
3.7 20.9 10.6 
1.85 20.9 5.0 
Fc 21.0 26.9 20.2 
15.0 26.9 15.0 
1.5 26.9 4.5 
5.0 26.9 3.9 
3.7 26.9 3.7 
CR2 
(fraction 3) 
30.0 13.0 13.0 
IS.0 13.0 13.0 
7.5 13.0 3.5 
3.1 13.0 1.7 
CH3 
(fraction 4) 
15.0 11.0 0.0 
10.5 11.0 0.0 
7.5 11.0 0.27 
be published). This finding correlates with the time 
course af the loss of susceptibility to trypsin. Al- 
though the cleavage of Fc appears to be a complex 
process involving a number of intermediate species 
the evidence presented here indicates that fragments 
closely corresponding to CH2 and CI,3 are produced 
in significant yields. 
In formulating the compact domain model Edel- 
man et al. [ 131 proposed that each domain had 
evolved to fulfil specific functions. Our data would 
suggest hat C, 2 functions to trigger the comple- 
ment system. This does not preclude other roles for 
C, 2 and the possible evolvement of this region in 
other effector functions is being actively studied at 
this time. The differentiation of Fc with regard to 
complement activation and heterocytotropic acti- 
vity seems clear since cH 2 does not participate in 
the passive cutaneous anaphylactic reaction and 
$3 is unreactive towards the complement system. 
The extent to which the complement fixing activities 
of intact IgC can be accounted for by isolated C,2 
remains to be fully evaluated. Previous work suggests 
that the complement binding site may occupy only 
whole digest 
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Fig. 2. a) Acid-urea starch gel electrophoresis, at pH 3.5, of 
the samples indicated. The cathode is on the left. bt Anti- 
genie relationships between: 1, Fc’; 2, pFc’ (prepared accord- 
ing to Turner and Bennich [3] ); 3, Fraction 4 and 4, Frac- 
tion 3, using antisera to Fc and CH2. 
a limited region of the CH2 sequence: Utsumi [ 141 
has shown that progressive degradation of rabbit Fc 
from the N-terminus results in the complete loss of 
complement fixing activity. Kehoe and Fougereau 
[lo] have demonstrated low level residual comple- 
ment furing activity in a CNI3r peptide derived from 
the CH2 region of a murine IgG 2a myeloma pro- 
tein The technique of studying complement fma- 
tion by molecules aggregated on polystyrene latex 
needs further characterization. The possible depen- 
dence of the complement fixing activity of C, 2 on 
the integrity of the Fc region raises questions con- 
cerning the domains. Our desire to examine these 
putative interactions provided the impetus to devel- 
op the methods for the isolation of intact domains 
described here. 
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